| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000024156 |
| Receipt No. | R000027786 |
| Scientific Title | Assessment of the prognosis of the patients of connective tissue disease. |
| Date of disclosure of the study information | 2016/09/26 |
| Last modified on | 2020/03/30 (Ver. 3) |
| Basic information | ||
| Public title | Assessment of the prognosis of the patients of connective tissue disease. | |
| Acronym | Assessment of the prognosis of the patients of connective tissue disease. | |
| Scientific Title | Assessment of the prognosis of the patients of connective tissue disease. | |
| Scientific Title:Acronym | Assessment of the prognosis of the patients of connective tissue disease. | |
| Region |
|
|
| Condition | ||
| Condition | rheumatoid arthritis, scleroderma, polymyositis-dermatomyositis, systemic lupus erythematosus, mixed connective tissue disease, Sjogren syndrome, eosinophilic granulomatosis with polyangiitis, granulomatosis with polyangiitis, microscopic polyangiitis, IgG4-related disease. | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Reveal prognostic factor of collagen disease and complications risk factors. |
| Basic objectives2 | Others |
| Basic objectives -Others | Overall survival
progression-free survival complications |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Overall survival |
| Key secondary outcomes | progression-free survival
complications |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who meet the following of one of the diagnostic criteria.
1) 2010 ACR/EULAR classification criteria for rheumatoid arthritis. 2) 2013 classification criteria for systemic sclerosis 3) Bohan and Peter criteria for polymyositis and dermatomyositis 4) 2012 SLICC classification criteria for systemic lupus erythematosus 5) 2004 Preliminary diagnostic criteria for mixed connective tissue disease proposed by Ministry of Health, Labour and Welfare in Japan. 6) 2012 ACR classification criteria for Sjogren's syndrome 7) 1990 ACR classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis) 8) 1990 ACR classification of Wegener's granulomatosis (granulomatosis and angiitis) 9) 1999 diagnostic criteria for microscopic polyangiitis by Ministry of Health and Welfare in Japan. 10) 2011 Comprehensive diagnostic criteria for IgG4-related disease by Ministry of Health, Labour and Welfare in Japan. |
|||
| Key exclusion criteria | 1) Patients who are judged to be inappropriate as a research subject by the principal investigator or research team members.
2) Patients who are considered to be difficult to obtain a valid consent. |
|||
| Target sample size | 150 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Yamaguchi University Hospital | ||||||
| Division name | Internal Medicine 2 | ||||||
| Zip code | 755-8505 | ||||||
| Address | 1-1-1,MinamiKogushi,Ube City,Yamaguchi Prefecture,Japan | ||||||
| TEL | 0836-22-2248 | ||||||
| mkubo@yamaguchi-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Yamaguchi University Hospital | ||||||
| Division name | Internal Medicine 2 | ||||||
| Zip code | 755-8505 | ||||||
| Address | 1-1-1,MinamiKogushi,Ube City,Yamaguchi Prefecture,Japan | ||||||
| TEL | 0836-22-2248 | ||||||
| Homepage URL | |||||||
| mkubo@yamaguchi-u.ac.jp | |||||||
| Sponsor | |
| Institute | Yamaguchi University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Center For Clinical Research, Yamaguchi University Hospital |
| Address | 1-1-1,MinamiKogushi,Ube City,Yamaguchi Prefecture,Japan |
| Tel | 0836-22-2428 |
| me223@yamaguchi-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 山口大学医学部付属病院(山口県) Yamaguchi University Hospital |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | This study is a prospective observational study that does not involve the intervention.
The subjects of the present study are collagen vascular disease patients who meet the selection criteria and are admitted to Yamaguchi University Hospital until December 2019 from September 2016. Patients are followed for five years and are evaluated a multi-factor analysis including its prognostic factor and risk factor of complications. Analysis items are such as a blood test findings, urinary findings, imaging findings, physiological laboratory findings and biopsy findings. Survival of the subject patients, exacerbation of collagen disease, complications are evaluated after five years of registration. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000027786 |